Pharmaceuticals and Biotechnology R&D Market - Global Outlook and Forecast 2021-2027

April 2021 | 112 pages | ID: PF23A038E9FBEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Pharmaceuticals and Biotechnology R&D in Global, including the following market information:

Global Pharmaceuticals and Biotechnology R&D Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Pharmaceuticals and Biotechnology R&D market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pharmaceuticals and Biotechnology R&D companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Pharmaceuticals and Biotechnology R&D Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Pharmaceuticals and Biotechnology R&D Market Segment Percentages, By Type, 2020 (%)

• Drug
• Medical Equipment
• Vaccine
• Others

China Pharmaceuticals and Biotechnology R&D Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Pharmaceuticals and Biotechnology R&D Market Segment Percentages, By Application, 2020 (%)

• Hospital
• Clinic
• Homecare
• Others

Global Pharmaceuticals and Biotechnology R&D Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Pharmaceuticals and Biotechnology R&D Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Pharmaceuticals and Biotechnology R&D Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Pharmaceuticals and Biotechnology R&D Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• ROCHE
• JOHNSON & JOHNSON
• MERCK
• NOVARTIS
• PFIZER
• SANOFI
• BAYER
• BRISTOL-MYERS SQUIBB
• ASTRAZENECA
• GLAXOSMITHKLINE
• ABBVIE
• ELI LILLY
• BOEHRINGER SOHN
• AMGEN
• GILEAD SCIENCES
• TAKEDA PHARMACEUTICAL
• NOVO NORDISK
• BIOGEN
• ABBOTT
• ASTELLAS PHARMA
• TEVA PHARMACEUTICAL INDUSTRIES

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Pharmaceuticals and Biotechnology R&D Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Pharmaceuticals and Biotechnology R&D Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PHARMACEUTICALS AND BIOTECHNOLOGY R&D OVERALL MARKET SIZE

2.1 Global Pharmaceuticals and Biotechnology R&D Market Size: 2021 VS 2027
2.2 Global Pharmaceuticals and Biotechnology R&D Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Pharmaceuticals and Biotechnology R&D Players in Global Market
3.2 Top Global Pharmaceuticals and Biotechnology R&D Companies Ranked by Revenue
3.3 Global Pharmaceuticals and Biotechnology R&D Revenue by Companies
3.4 Top 3 and Top 5 Pharmaceuticals and Biotechnology R&D Companies in Global Market, by Revenue in 2020
3.5 Global Companies Pharmaceuticals and Biotechnology R&D Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pharmaceuticals and Biotechnology R&D Players in Global Market
  3.6.1 List of Global Tier 1 Pharmaceuticals and Biotechnology R&D Companies
  3.6.2 List of Global Tier 2 and Tier 3 Pharmaceuticals and Biotechnology R&D Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Pharmaceuticals and Biotechnology R&D Market Size Markets, 2021 & 2027
  4.1.2 Drug
  4.1.3 Medical Equipment
  4.1.4 Vaccine
  4.1.5 Others
4.2 By Type - Global Pharmaceuticals and Biotechnology R&D Revenue & Forecasts
  4.2.1 By Type - Global Pharmaceuticals and Biotechnology R&D Revenue, 2016-2021
  4.2.2 By Type - Global Pharmaceuticals and Biotechnology R&D Revenue, 2022-2027
  4.2.3 By Type - Global Pharmaceuticals and Biotechnology R&D Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Pharmaceuticals and Biotechnology R&D Market Size, 2021 & 2027
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Homecare
  5.1.5 Others
5.2 By Application - Global Pharmaceuticals and Biotechnology R&D Revenue & Forecasts
  5.2.1 By Application - Global Pharmaceuticals and Biotechnology R&D Revenue, 2016-2021
  5.2.2 By Application - Global Pharmaceuticals and Biotechnology R&D Revenue, 2022-2027
  5.2.3 By Application - Global Pharmaceuticals and Biotechnology R&D Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Pharmaceuticals and Biotechnology R&D Market Size, 2021 & 2027
6.2 By Region - Global Pharmaceuticals and Biotechnology R&D Revenue & Forecasts
  6.2.1 By Region - Global Pharmaceuticals and Biotechnology R&D Revenue, 2016-2021
  6.2.2 By Region - Global Pharmaceuticals and Biotechnology R&D Revenue, 2022-2027
  6.2.3 By Region - Global Pharmaceuticals and Biotechnology R&D Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Pharmaceuticals and Biotechnology R&D Revenue, 2016-2027
  6.3.2 US Pharmaceuticals and Biotechnology R&D Market Size, 2016-2027
  6.3.3 Canada Pharmaceuticals and Biotechnology R&D Market Size, 2016-2027
  6.3.4 Mexico Pharmaceuticals and Biotechnology R&D Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Pharmaceuticals and Biotechnology R&D Revenue, 2016-2027
  6.4.2 Germany Pharmaceuticals and Biotechnology R&D Market Size, 2016-2027
  6.4.3 France Pharmaceuticals and Biotechnology R&D Market Size, 2016-2027
  6.4.4 U.K. Pharmaceuticals and Biotechnology R&D Market Size, 2016-2027
  6.4.5 Italy Pharmaceuticals and Biotechnology R&D Market Size, 2016-2027
  6.4.6 Russia Pharmaceuticals and Biotechnology R&D Market Size, 2016-2027
  6.4.7 Nordic Countries Pharmaceuticals and Biotechnology R&D Market Size, 2016-2027
  6.4.8 Benelux Pharmaceuticals and Biotechnology R&D Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Pharmaceuticals and Biotechnology R&D Revenue, 2016-2027
  6.5.2 China Pharmaceuticals and Biotechnology R&D Market Size, 2016-2027
  6.5.3 Japan Pharmaceuticals and Biotechnology R&D Market Size, 2016-2027
  6.5.4 South Korea Pharmaceuticals and Biotechnology R&D Market Size, 2016-2027
  6.5.5 Southeast Asia Pharmaceuticals and Biotechnology R&D Market Size, 2016-2027
  6.5.6 India Pharmaceuticals and Biotechnology R&D Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Pharmaceuticals and Biotechnology R&D Revenue, 2016-2027
  6.6.2 Brazil Pharmaceuticals and Biotechnology R&D Market Size, 2016-2027
  6.6.3 Argentina Pharmaceuticals and Biotechnology R&D Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Pharmaceuticals and Biotechnology R&D Revenue, 2016-2027
  6.7.2 Turkey Pharmaceuticals and Biotechnology R&D Market Size, 2016-2027
  6.7.3 Israel Pharmaceuticals and Biotechnology R&D Market Size, 2016-2027
  6.7.4 Saudi Arabia Pharmaceuticals and Biotechnology R&D Market Size, 2016-2027
  6.7.5 UAE Pharmaceuticals and Biotechnology R&D Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 ROCHE
  7.1.1 ROCHE Corporate Summary
  7.1.2 ROCHE Business Overview
  7.1.3 ROCHE Pharmaceuticals and Biotechnology R&D Major Product Offerings
  7.1.4 ROCHE Pharmaceuticals and Biotechnology R&D Revenue in Global (2016-2021)
  7.1.5 ROCHE Key News
7.2 JOHNSON & JOHNSON
  7.2.1 JOHNSON & JOHNSON Corporate Summary
  7.2.2 JOHNSON & JOHNSON Business Overview
  7.2.3 JOHNSON & JOHNSON Pharmaceuticals and Biotechnology R&D Major Product Offerings
  7.2.4 JOHNSON & JOHNSON Pharmaceuticals and Biotechnology R&D Revenue in Global (2016-2021)
  7.2.5 JOHNSON & JOHNSON Key News
7.3 MERCK
  7.3.1 MERCK Corporate Summary
  7.3.2 MERCK Business Overview
  7.3.3 MERCK Pharmaceuticals and Biotechnology R&D Major Product Offerings
  7.3.4 MERCK Pharmaceuticals and Biotechnology R&D Revenue in Global (2016-2021)
  7.3.5 MERCK Key News
7.4 NOVARTIS
  7.4.1 NOVARTIS Corporate Summary
  7.4.2 NOVARTIS Business Overview
  7.4.3 NOVARTIS Pharmaceuticals and Biotechnology R&D Major Product Offerings
  7.4.4 NOVARTIS Pharmaceuticals and Biotechnology R&D Revenue in Global (2016-2021)
  7.4.5 NOVARTIS Key News
7.5 PFIZER
  7.5.1 PFIZER Corporate Summary
  7.5.2 PFIZER Business Overview
  7.5.3 PFIZER Pharmaceuticals and Biotechnology R&D Major Product Offerings
  7.5.4 PFIZER Pharmaceuticals and Biotechnology R&D Revenue in Global (2016-2021)
  7.5.5 PFIZER Key News
7.6 SANOFI
  7.6.1 SANOFI Corporate Summary
  7.6.2 SANOFI Business Overview
  7.6.3 SANOFI Pharmaceuticals and Biotechnology R&D Major Product Offerings
  7.6.4 SANOFI Pharmaceuticals and Biotechnology R&D Revenue in Global (2016-2021)
  7.6.5 SANOFI Key News
7.7 BAYER
  7.7.1 BAYER Corporate Summary
  7.7.2 BAYER Business Overview
  7.7.3 BAYER Pharmaceuticals and Biotechnology R&D Major Product Offerings
  7.4.4 BAYER Pharmaceuticals and Biotechnology R&D Revenue in Global (2016-2021)
  7.7.5 BAYER Key News
7.8 BRISTOL-MYERS SQUIBB
  7.8.1 BRISTOL-MYERS SQUIBB Corporate Summary
  7.8.2 BRISTOL-MYERS SQUIBB Business Overview
  7.8.3 BRISTOL-MYERS SQUIBB Pharmaceuticals and Biotechnology R&D Major Product Offerings
  7.8.4 BRISTOL-MYERS SQUIBB Pharmaceuticals and Biotechnology R&D Revenue in Global (2016-2021)
  7.8.5 BRISTOL-MYERS SQUIBB Key News
7.9 ASTRAZENECA
  7.9.1 ASTRAZENECA Corporate Summary
  7.9.2 ASTRAZENECA Business Overview
  7.9.3 ASTRAZENECA Pharmaceuticals and Biotechnology R&D Major Product Offerings
  7.9.4 ASTRAZENECA Pharmaceuticals and Biotechnology R&D Revenue in Global (2016-2021)
  7.9.5 ASTRAZENECA Key News
7.10 GLAXOSMITHKLINE
  7.10.1 GLAXOSMITHKLINE Corporate Summary
  7.10.2 GLAXOSMITHKLINE Business Overview
  7.10.3 GLAXOSMITHKLINE Pharmaceuticals and Biotechnology R&D Major Product Offerings
  7.10.4 GLAXOSMITHKLINE Pharmaceuticals and Biotechnology R&D Revenue in Global (2016-2021)
  7.10.5 GLAXOSMITHKLINE Key News
7.11 ABBVIE
  7.11.1 ABBVIE Corporate Summary
  7.11.2 ABBVIE Business Overview
  7.11.3 ABBVIE Pharmaceuticals and Biotechnology R&D Major Product Offerings
  7.11.4 ABBVIE Pharmaceuticals and Biotechnology R&D Revenue in Global (2016-2021)
  7.11.5 ABBVIE Key News
7.12 ELI LILLY
  7.12.1 ELI LILLY Corporate Summary
  7.12.2 ELI LILLY Business Overview
  7.12.3 ELI LILLY Pharmaceuticals and Biotechnology R&D Major Product Offerings
  7.12.4 ELI LILLY Pharmaceuticals and Biotechnology R&D Revenue in Global (2016-2021)
  7.12.5 ELI LILLY Key News
7.13 BOEHRINGER SOHN
  7.13.1 BOEHRINGER SOHN Corporate Summary
  7.13.2 BOEHRINGER SOHN Business Overview
  7.13.3 BOEHRINGER SOHN Pharmaceuticals and Biotechnology R&D Major Product Offerings
  7.13.4 BOEHRINGER SOHN Pharmaceuticals and Biotechnology R&D Revenue in Global (2016-2021)
  7.13.5 BOEHRINGER SOHN Key News
7.14 AMGEN
  7.14.1 AMGEN Corporate Summary
  7.14.2 AMGEN Business Overview
  7.14.3 AMGEN Pharmaceuticals and Biotechnology R&D Major Product Offerings
  7.14.4 AMGEN Pharmaceuticals and Biotechnology R&D Revenue in Global (2016-2021)
  7.14.5 AMGEN Key News
7.15 GILEAD SCIENCES
  7.15.1 GILEAD SCIENCES Corporate Summary
  7.15.2 GILEAD SCIENCES Business Overview
  7.15.3 GILEAD SCIENCES Pharmaceuticals and Biotechnology R&D Major Product Offerings
  7.15.4 GILEAD SCIENCES Pharmaceuticals and Biotechnology R&D Revenue in Global (2016-2021)
  7.15.5 GILEAD SCIENCES Key News
7.16 TAKEDA PHARMACEUTICAL
  7.16.1 TAKEDA PHARMACEUTICAL Corporate Summary
  7.16.2 TAKEDA PHARMACEUTICAL Business Overview
  7.16.3 TAKEDA PHARMACEUTICAL Pharmaceuticals and Biotechnology R&D Major Product Offerings
  7.16.4 TAKEDA PHARMACEUTICAL Pharmaceuticals and Biotechnology R&D Revenue in Global (2016-2021)
  7.16.5 TAKEDA PHARMACEUTICAL Key News
7.17 NOVO NORDISK
  7.17.1 NOVO NORDISK Corporate Summary
  7.17.2 NOVO NORDISK Business Overview
  7.17.3 NOVO NORDISK Pharmaceuticals and Biotechnology R&D Major Product Offerings
  7.17.4 NOVO NORDISK Pharmaceuticals and Biotechnology R&D Revenue in Global (2016-2021)
  7.17.5 NOVO NORDISK Key News
7.18 BIOGEN
  7.18.1 BIOGEN Corporate Summary
  7.18.2 BIOGEN Business Overview
  7.18.3 BIOGEN Pharmaceuticals and Biotechnology R&D Major Product Offerings
  7.18.4 BIOGEN Pharmaceuticals and Biotechnology R&D Revenue in Global (2016-2021)
  7.18.5 BIOGEN Key News
7.19 ABBOTT
  7.19.1 ABBOTT Corporate Summary
  7.19.2 ABBOTT Business Overview
  7.19.3 ABBOTT Pharmaceuticals and Biotechnology R&D Major Product Offerings
  7.19.4 ABBOTT Pharmaceuticals and Biotechnology R&D Revenue in Global (2016-2021)
  7.19.5 ABBOTT Key News
7.20 ASTELLAS PHARMA
  7.20.1 ASTELLAS PHARMA Corporate Summary
  7.20.2 ASTELLAS PHARMA Business Overview
  7.20.3 ASTELLAS PHARMA Pharmaceuticals and Biotechnology R&D Major Product Offerings
  7.20.4 ASTELLAS PHARMA Pharmaceuticals and Biotechnology R&D Revenue in Global (2016-2021)
  7.20.5 ASTELLAS PHARMA Key News
7.21 TEVA PHARMACEUTICAL INDUSTRIES
  7.21.1 TEVA PHARMACEUTICAL INDUSTRIES Corporate Summary
  7.21.2 TEVA PHARMACEUTICAL INDUSTRIES Business Overview
  7.21.3 TEVA PHARMACEUTICAL INDUSTRIES Pharmaceuticals and Biotechnology R&D Major Product Offerings
  7.21.4 TEVA PHARMACEUTICAL INDUSTRIES Pharmaceuticals and Biotechnology R&D Revenue in Global (2016-2021)
  7.21.5 TEVA PHARMACEUTICAL INDUSTRIES Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Pharmaceuticals and Biotechnology R&D Market Opportunities & Trends in Global Market
Table 2. Pharmaceuticals and Biotechnology R&D Market Drivers in Global Market
Table 3. Pharmaceuticals and Biotechnology R&D Market Restraints in Global Market
Table 4. Key Players of Pharmaceuticals and Biotechnology R&D in Global Market
Table 5. Top Pharmaceuticals and Biotechnology R&D Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Pharmaceuticals and Biotechnology R&D Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Pharmaceuticals and Biotechnology R&D Revenue Share by Companies, 2016-2021
Table 8. Global Companies Pharmaceuticals and Biotechnology R&D Product Type
Table 9. List of Global Tier 1 Pharmaceuticals and Biotechnology R&D Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pharmaceuticals and Biotechnology R&D Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Pharmaceuticals and Biotechnology R&D Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Pharmaceuticals and Biotechnology R&D Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Pharmaceuticals and Biotechnology R&D Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Pharmaceuticals and Biotechnology R&D Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2022-2027
Table 30. ROCHE Corporate Summary
Table 31. ROCHE Pharmaceuticals and Biotechnology R&D Product Offerings
Table 32. ROCHE Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), (2016-2021)
Table 33. JOHNSON & JOHNSON Corporate Summary
Table 34. JOHNSON & JOHNSON Pharmaceuticals and Biotechnology R&D Product Offerings
Table 35. JOHNSON & JOHNSON Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), (2016-2021)
Table 36. MERCK Corporate Summary
Table 37. MERCK Pharmaceuticals and Biotechnology R&D Product Offerings
Table 38. MERCK Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), (2016-2021)
Table 39. NOVARTIS Corporate Summary
Table 40. NOVARTIS Pharmaceuticals and Biotechnology R&D Product Offerings
Table 41. NOVARTIS Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), (2016-2021)
Table 42. PFIZER Corporate Summary
Table 43. PFIZER Pharmaceuticals and Biotechnology R&D Product Offerings
Table 44. PFIZER Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), (2016-2021)
Table 45. SANOFI Corporate Summary
Table 46. SANOFI Pharmaceuticals and Biotechnology R&D Product Offerings
Table 47. SANOFI Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), (2016-2021)
Table 48. BAYER Corporate Summary
Table 49. BAYER Pharmaceuticals and Biotechnology R&D Product Offerings
Table 50. BAYER Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), (2016-2021)
Table 51. BRISTOL-MYERS SQUIBB Corporate Summary
Table 52. BRISTOL-MYERS SQUIBB Pharmaceuticals and Biotechnology R&D Product Offerings
Table 53. BRISTOL-MYERS SQUIBB Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), (2016-2021)
Table 54. ASTRAZENECA Corporate Summary
Table 55. ASTRAZENECA Pharmaceuticals and Biotechnology R&D Product Offerings
Table 56. ASTRAZENECA Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), (2016-2021)
Table 57. GLAXOSMITHKLINE Corporate Summary
Table 58. GLAXOSMITHKLINE Pharmaceuticals and Biotechnology R&D Product Offerings
Table 59. GLAXOSMITHKLINE Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), (2016-2021)
Table 60. ABBVIE Corporate Summary
Table 61. ABBVIE Pharmaceuticals and Biotechnology R&D Product Offerings
Table 62. ABBVIE Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), (2016-2021)
Table 63. ELI LILLY Corporate Summary
Table 64. ELI LILLY Pharmaceuticals and Biotechnology R&D Product Offerings
Table 65. ELI LILLY Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), (2016-2021)
Table 66. BOEHRINGER SOHN Corporate Summary
Table 67. BOEHRINGER SOHN Pharmaceuticals and Biotechnology R&D Product Offerings
Table 68. BOEHRINGER SOHN Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), (2016-2021)
Table 69. AMGEN Corporate Summary
Table 70. AMGEN Pharmaceuticals and Biotechnology R&D Product Offerings
Table 71. AMGEN Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), (2016-2021)
Table 72. GILEAD SCIENCES Corporate Summary
Table 73. GILEAD SCIENCES Pharmaceuticals and Biotechnology R&D Product Offerings
Table 74. GILEAD SCIENCES Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), (2016-2021)
Table 75. TAKEDA PHARMACEUTICAL Corporate Summary
Table 76. TAKEDA PHARMACEUTICAL Pharmaceuticals and Biotechnology R&D Product Offerings
Table 77. TAKEDA PHARMACEUTICAL Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), (2016-2021)
Table 78. NOVO NORDISK Corporate Summary
Table 79. NOVO NORDISK Pharmaceuticals and Biotechnology R&D Product Offerings
Table 80. NOVO NORDISK Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), (2016-2021)
Table 81. BIOGEN Corporate Summary
Table 82. BIOGEN Pharmaceuticals and Biotechnology R&D Product Offerings
Table 83. BIOGEN Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), (2016-2021)
Table 84. ABBOTT Corporate Summary
Table 85. ABBOTT Pharmaceuticals and Biotechnology R&D Product Offerings
Table 86. ABBOTT Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), (2016-2021)
Table 87. ASTELLAS PHARMA Corporate Summary
Table 88. ASTELLAS PHARMA Pharmaceuticals and Biotechnology R&D Product Offerings
Table 89. ASTELLAS PHARMA Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), (2016-2021)
Table 90. TEVA PHARMACEUTICAL INDUSTRIES Corporate Summary
Table 91. TEVA PHARMACEUTICAL INDUSTRIES Pharmaceuticals and Biotechnology R&D Product Offerings
Table 92. TEVA PHARMACEUTICAL INDUSTRIES Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Pharmaceuticals and Biotechnology R&D Segment by Type
Figure 2. Pharmaceuticals and Biotechnology R&D Segment by Application
Figure 3. Global Pharmaceuticals and Biotechnology R&D Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Pharmaceuticals and Biotechnology R&D Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Pharmaceuticals and Biotechnology R&D Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pharmaceuticals and Biotechnology R&D Revenue in 2020
Figure 8. By Type - Global Pharmaceuticals and Biotechnology R&D Revenue Market Share, 2016-2027
Figure 9. By Application - Global Pharmaceuticals and Biotechnology R&D Revenue Market Share, 2016-2027
Figure 10. By Region - Global Pharmaceuticals and Biotechnology R&D Revenue Market Share, 2016-2027
Figure 11. By Country - North America Pharmaceuticals and Biotechnology R&D Revenue Market Share, 2016-2027
Figure 12. US Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Pharmaceuticals and Biotechnology R&D Revenue Market Share, 2016-2027
Figure 16. Germany Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2016-2027
Figure 17. France Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Pharmaceuticals and Biotechnology R&D Revenue Market Share, 2016-2027
Figure 24. China Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2016-2027
Figure 28. India Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Pharmaceuticals and Biotechnology R&D Revenue Market Share, 2016-2027
Figure 30. Brazil Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Pharmaceuticals and Biotechnology R&D Revenue Market Share, 2016-2027
Figure 33. Turkey Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2016-2027
Figure 37. ROCHE Pharmaceuticals and Biotechnology R&D Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. JOHNSON & JOHNSON Pharmaceuticals and Biotechnology R&D Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. MERCK Pharmaceuticals and Biotechnology R&D Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. NOVARTIS Pharmaceuticals and Biotechnology R&D Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. PFIZER Pharmaceuticals and Biotechnology R&D Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. SANOFI Pharmaceuticals and Biotechnology R&D Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. BAYER Pharmaceuticals and Biotechnology R&D Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. BRISTOL-MYERS SQUIBB Pharmaceuticals and Biotechnology R&D Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. ASTRAZENECA Pharmaceuticals and Biotechnology R&D Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. GLAXOSMITHKLINE Pharmaceuticals and Biotechnology R&D Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. ABBVIE Pharmaceuticals and Biotechnology R&D Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. ELI LILLY Pharmaceuticals and Biotechnology R&D Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. BOEHRINGER SOHN Pharmaceuticals and Biotechnology R&D Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. AMGEN Pharmaceuticals and Biotechnology R&D Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. GILEAD SCIENCES Pharmaceuticals and Biotechnology R&D Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. TAKEDA PHARMACEUTICAL Pharmaceuticals and Biotechnology R&D Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 53. NOVO NORDISK Pharmaceuticals and Biotechnology R&D Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 54. BIOGEN Pharmaceuticals and Biotechnology R&D Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 55. ABBOTT Pharmaceuticals and Biotechnology R&D Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 56. ASTELLAS PHARMA Pharmaceuticals and Biotechnology R&D Revenue Year Over Year Growth (US$, Mn) & (2016-2021)